Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00002527 · ClinicalTrials.gov registry record · Phase 3

Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed

A Phase 3 study of Colorectal Cancer, sponsored by Alliance for Clinical Trials in Oncology.

Completed
Registry status
Phase 3
Development phase
635
Enrollment target
20
Study locations

NCT00002527 is a Phase 3 study of Colorectal Cancer that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 635 participants, below the 1,509-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (58% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00002527, a Phase 3 study of Colorectal Cancer, has completed, sponsored by Alliance for Clinical Trials in Oncology.

COMPLETED
Registry status
Phase 3
Development phase
635 participants
Enrollment target
20
Study locations

Study Summary

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of aspirin may be an effective way to prevent the recurrence of polyps in colorectal cancer. PURPOSE: Randomized phase III trial to study the effectiveness of aspirin in treating patients who have stage I, stage II, or stage III colorectal cancer that has been surgically removed.

Conditions Studied

Colorectal Cancer

Interventions

  • OTHER placebo
  • DRUG aspirin

Study Locations (20)

Iowa

  • CCOP - Cedar Rapids Oncology Project - Cedar Rapids
  • CCOP - Iowa Oncology Research Association - Des Moines
  • University of Iowa Hospitals and Clinics - Iowa City
  • Siouxland Hematology-Oncology - Sioux City

Illinois

  • University of Chicago Cancer Research Center - Chicago
  • CCOP - Illinois Oncology Research Association - Peoria
  • CCOP - Carle Cancer Center - Urbana

Minnesota

  • University of Minnesota Cancer Center - Minneapolis
  • Mayo Clinic Cancer Center - Rochester
  • CentraCare Clinic - Saint Cloud

Massachusetts

  • Massachusetts General Hospital Cancer Center - Boston
  • University of Massachusetts Memorial Medical Center - Worcester

Missouri

  • Ellis Fischel Cancer Center - Columbia - Columbia
  • Barnes-Jewish Hospital - St Louis

Arizona

  • CCOP - Scottsdale Oncology Program - Scottsdale

California

  • UCSF Cancer Center and Cancer Research Institute - San Francisco

Florida

  • CCOP - Mount Sinai Medical Center - Miami Beach

Trial Details

FieldValue
Enrollment Target 635 participants
Start Date 1993-05
Est. Completion 2006-01
Phase Phase 3

Sponsor

Alliance for Clinical Trials in Oncology

446 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00002527

The ClinicalTrials.gov registry entry for NCT00002527 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 635 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,509-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (58% lower). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT00002527 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Iowa, Illinois, Minnesota.

Frequently Asked Questions

What is clinical trial NCT00002527 about?

NCT00002527 is a clinical study titled "Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed". RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of aspirin may be an effective way to prevent the recurrence of polyps in colorectal cancer. PURPOSE: Randomized phase III trial to study the effectiveness of aspirin in...

What is the current status of trial NCT00002527?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 635 participants. The study started on 1993-05. Estimated completion is 2006-01.

What conditions does trial NCT00002527 study?

This clinical trial studies the following conditions: Colorectal Cancer.

What interventions are being tested in trial NCT00002527?

The interventions under investigation include: placebo (OTHER), aspirin (DRUG).

Who is sponsoring clinical trial NCT00002527?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00002527 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Illinois, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Colorectal Cancer

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.